t.demir
TL2 · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 13 March 2025 · last posted 2d
70 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #73 · Practice › Interactions · 26 Jul 2026 · 23 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on Delayed gastric emptying and…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #75 · Practice › Administration · 23 Jul 2026 · 21 likes Completing a dose was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Follow-up: Sleep quality changes during weight loss Replied, post #75 · Wellbeing › Sleep · 21 Jul 2026 · 33 likes Post #73 and I disagree about the size of the effect, not about the direction. A referral for a proper sleep study answers in one night what months of forum discussion…
-
Sleep quality changes during weight loss Replied, post #20 · Wellbeing › Sleep · 16 Jul 2026 · 17 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here.
-
[2026 update] Waist circumference technique and its repeatability Replied, post #23 · Outcomes › Progress reports · 9 Jul 2026 · 30 likes This follows post #22 rather than contradicting it. Rate of change matters more than the absolute number for most of the questions people ask about their own series.
-
[2026 update] Documenting an adverse event properly Replied, post #3 · Safety › Adverse events · 7 Jul 2026 · 17 likes Everything in the opening post holds. The case it does not cover is the one I have. Medullary thyroid carcinoma is the reason these compounds are contraindicated in…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #40 · Access › Pricing · 6 Jul 2026 · 0 likes Taking post #37 at face value and following it one step further. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That…
-
Coming back to: Telehealth prescribing models in the US Replied, post #7 · Regional › North America · 6 Jul 2026 · 27 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different. That is the version I use. It may not be the version…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #65 · Start Here › Welcome · 6 Jul 2026 · 24 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #57 · Analytics › Home & field testing · 6 Jul 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #22 · Compounds › Retatrutide · 28 Jun 2026 · 26 likes On post #18 — agreed on the reasoning, with one qualification. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an…
-
Injection volume, overload, and peak distortion Replied, post #6 · Analytics › HPLC & UHPLC · 13 May 2026 · 5 likes Post #2 put the caveat in the right place and I want to underline it. Distinguishing three things in the injection volume discussion that keep getting used…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #33 · Safety › Contraindications · 9 May 2026 · 8 likes Post #31 and I disagree about the size of the effect, not about the direction. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
-
Official shortage notices and what they authorise Replied, post #41 · Access › Shortages · 9 May 2026 · 8 likes This follows post #40 rather than contradicting it. Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating…
-
[2026 update] What a good consultation looks like from the other side Replied, post #27 · Clinical › Prescriber conversations · 21 Apr 2026 · 14 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. One more caveat and then I will…
-
About the Bloodwork category Replied, post #9 · Clinical › Bloodwork · 18 Apr 2026 · 0 likes Post #7 describes the usual case. This is about the unusual one. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is…
-
Follow-up: State-level differences that actually matter Replied, post #55 · Regional › North America · 7 Apr 2026 · 23 likes Reading back through the State-level differences threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Request declined, with reasoning — what changed since Replied, post #25 · Meta › Feature requests · 30 Mar 2026 · 4 likes Picking up post #23: that is the part I would want checked first. Request: an export of my own posts. Not for any dramatic reason — I want to search my own history…
-
Grapefruit: why this class is not the class that cares Replied, post #91 · Practice › Interactions · 28 Mar 2026 · 21 likes Grapefruit is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #10 · Compounds › Retatrutide · 28 Mar 2026 · 18 likes Post #8 put the caveat in the right place and I want to underline it. Checked the TRIUMPH claim against the primary source this morning. It survives, with a narrower…
-
Transporting a vial for a weekend away — a second dataset Replied, post #13 · Practice › Storage & stability · 24 Mar 2026 · 23 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
IGF-1 as a surrogate endpoint and its limitations Replied, post #10 · Compounds › Secretagogues & GH axis · 24 Mar 2026 · 30 likes IGF-1 as a downstream marker is more informative than a single growth hormone measurement because it integrates over a longer period. It is still a proxy, and proxies…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #50 · Data & Tools › Calculators · 16 Mar 2026 · 1 like One more thing on titration planner refuses that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #56 · Research Methods › N-of-1 designs · 12 Mar 2026 · 26 likes Post #54 answers the question as asked. The question underneath it is different. A rolling mean over several days is far more informative than any single reading for…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #30 · Compounds › Repair & healing peptides · 10 Mar 2026 · 0 likes This follows post #28 rather than contradicting it. I keep a log for Reading a preclinical wound-healing model specifically because my memory of it turned out to be…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #81 · Outcomes › Progress reports · 18 Feb 2026 · 16 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. Noting that the question and the…
-
Revisiting: Absolute versus relative contraindications Replied, post #24 · Safety › Contraindications · 13 Feb 2026 · 0 likes Agreed on Absolute versus relative contraindications, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #68 · Practice › Side effects · 10 Jan 2026 · 3 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #44 · Documentation › Doc review · 29 Dec 2025 · 9 likes Building on post #41 rather than restating it. Reading this evidence digest thread as someone who came in with a fixed view: the third and seventh replies moved me and…
-
Prescription requirements and telehealth models Replied, post #95 · Sourcing › Regulatory · 27 Dec 2025 · 6 likes What I can speak to on prescription requirements and telehealth models is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do…
-
About the Other compounds category Replied, post #6 · Compounds › Other compounds · 20 Dec 2025 · 0 likes On post #2 — agreed on the reasoning, with one qualification. The tanning compounds carry a specific practical point that is not pharmacological: any change to a…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #16 · Clinical › Bloodwork · 27 Nov 2025 · 4 likes On post #15 — agreed on the reasoning, with one qualification. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #13 · Data & Tools › Calculators · 20 Nov 2025 · 0 likes Post #10 answers the question as asked. The question underneath it is different. My understanding of Feature request is a few years old and may have been superseded. If…
-
Pen dose counters: what a click does and does not guarantee Replied, post #82 · Devices › Pens & autoinjectors · 18 Nov 2025 · 7 likes Post #80 and I disagree about the size of the effect, not about the direction. The residual left in a cartridge at the end is deliberate overfill and is not a dose you…
-
What a confidence interval means, from scratch — the long version Replied, post #18 · Research Methods › Statistics · 17 Nov 2025 · 22 likes Distinguishing three things in the confidence interval discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #9 · Compounds › Oral incretins · 9 Nov 2025 · 4 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #11 · Compounds › Retatrutide · 3 Nov 2025 · 0 likes Worth separating two things that post #7 runs together. The phase 2 obesity data is genuinely striking and it is phase 2 data. Sample sizes at that stage characterise a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #14 · Compounds › Semaglutide · 22 Sep 2025 · 21 likes Post #12 put the caveat in the right place and I want to underline it. Where I have landed on semaglutide half-life, having got it wrong once in public: the direction…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #16 · Practice › Interactions · 13 Sep 2025 · 27 likes Adding a small correction to the Warfarin and altered intake summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #80 · Clinical › Special populations · 13 Sep 2025 · 0 likes The confident answers on History of disordered eating and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #113 · Data & Tools › Calculators · 11 Sep 2025 · 3 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #48 · Practice › Side effects · 9 Sep 2025 · 26 likes The arithmetic in post #45 is right; the assumption feeding it is the part to check. On nausea timeline the community has more anecdote than the confidence in this…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #7 · Clinical › Bloodwork · 2 Sep 2025 · 3 likes I would call the community position on lipase elevation without symptoms likely rather than established, and I would be comfortable defending that hedge.
-
Thyroid function tests during substantial weight change Replied, post #40 · Clinical › Bloodwork · 24 Aug 2025 · 30 likes Bookmarking this. I will come back when I have something worth adding.
-
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #4 · Analytics › COA interpretation · 14 Aug 2025 · 18 likes Everything in the opening post holds. The case it does not cover is the one I have. A document that puts the specification in the result column has told you the release…
-
When a preprint is the best available evidence and we say so Replied, post #53 · Evidence › Preprints · 13 Aug 2025 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
-
Meeting a protein target on a suppressed appetite Replied, post #11 · Nutrition & Training › Protein & intake · 22 Jul 2025 · 16 likes Fair, and the limits you put on it are the part I will remember.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #47 · Compounds › Semaglutide · 29 Jun 2025 · 5 likes On Semaglutide half-life I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #112 · Compounds › Semaglutide · 10 May 2025 · 22 likes Answering the question post #108 raises rather than the one it answers. Where I have landed on SELECT, having got it wrong once in public: the direction is clear, the…
-
Follow-up: Documentation that appears only after payment Replied, post #46 · Sourcing › Red flags · 4 May 2025 · 3 likes Where I part company with post #43, and it is a narrow parting. Careful with the language on Documentation. "Not detected" and "not present" are different findings and…
-
Dizziness on standing: the ordinary explanation first Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 21 Apr 2025 · 0 likes I would put moderate confidence on the mainstream reading of dizziness on standing and no more. That is not scepticism for its own sake; it is where the sourcing…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #60 · Analytics › Mass spectrometry · 8 Apr 2025 · 23 likes Where I have landed on adducts, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #132 · Access › International · 29 Mar 2025 · 21 likes I read post #128 twice before replying, because I had assumed the opposite. Cross-border prescribing and cross-border dispensing are different questions with different…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 1 like Post #43 and I disagree about the size of the effect, not about the direction. Is synergy the right word for the combination data? A phase 2 trial cannot establish…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #31 · Compounds › Secretagogues & GH axis · 26 Mar 2025 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Maintainer handover: how it works Replied, post #47 · Meta › Wiki maintenance · 16 Mar 2025 · 5 likes Taking post #46 at face value and following it one step further. Adding a small correction to the maintainer handover summary above rather than a disagreement with it.…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #116 · Data & Tools › Calculators · 5 Mar 2025 · 3 likes Taking post #115 at face value and following it one step further. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #38 · Documentation › Doc review · 20 Feb 2025 · 32 likes This follows post #35 rather than contradicting it. Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document…
-
A supplier that answers analytical questions with restated claims Replied, post #19 · Sourcing › Red flags · 4 Feb 2025 · 0 likes Post #15 put the caveat in the right place and I want to underline it. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure"…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #62 · Data & Tools › Calculators · 23 Jan 2025 · 0 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later. I would…
-
Recovery when intake is low: what to cut first Replied, post #74 · Nutrition & Training › Resistance training · 14 Jan 2025 · 0 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #142 · Analytics › COA interpretation · 6 Dec 2024 · 5 likes Answering the question post #138 raises rather than the one it answers. I have been on both sides of the field-by-field walk through a certificate argument in this…
-
Identical chromatograms across two different lots Replied, post #47 · Sourcing › Red flags · 9 Nov 2024 · 17 likes Worth separating two things that post #44 runs together. Identical chromatograms is a good example of a question where the honest answer is boring and the interesting…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #96 · Compounds › Other compounds · 5 Nov 2024 · 18 likes Picking up post #93: that is the part I would want checked first. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #25 · Pharmacology › Formulation chemistry · 28 Oct 2024 · 1 like Worth separating two things that post #21 runs together. Aggregation is concentration-dependent, which is why reconstituting to a high concentration is not always the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #3 · Clinical › Prescriber conversations · 23 Oct 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Reading it again, the caveat…
-
Progressive overload when the scale is falling — one year on Replied, post #118 · Nutrition & Training › Resistance training · 3 Oct 2024 · 23 likes Adding the measurement that post #117 says would settle it. Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #30 · Clinical › Bloodwork · 15 Sep 2024 · 0 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Sample handling before analysis affects several analytes, and a haemolysed sample…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #6 · Sourcing › Independent verification · 19 Aug 2024 · 8 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
The mass-error checker and its intended scope Replied, post #131 · Data & Tools › Calculators · 17 Jul 2024 · 0 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…